Regulating Human Embryonic Stem Cell in China: A Comparative Study on Human Embryonic Stem Cell’s Patentability and Morality in US and EU - Image 1

£74.50

Springer Regulating Human Embryonic Stem Cell in China: A Comparative Study on Human Embryonic Stem Cell’s Patentability and Morality in US and EU

Name: Regulating Human Embryonic Stem Cell in China: A Comparative Study on Human Embryonic Stem Cell's Patentability and Morality in US and EU
Brand: Springer
Price: 75.73 GBP
Availability: InStock

White

International

Price History & Forecast

Last 29 days • 29 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 29 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £76 (22 days, 75.9%)

Price range: £75 - £76

Price levels: 2 different prices over 29 days

Description

Product Description The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal funding control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research. From the Back Cover The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research. About the Author Li Jiang is currently a lecturer in Kenneth Wang School of Law, Soochow University. Born in China, Li Jiang was educated at Shandong University, China and graduated with a Bachelors degree in Biotechnology. Li Jiang gained her PhD degree at Bangor University Law School in 2014. Jiang’s research looks at the scope of patentability in respect of the application of the moral exclusion to human embryonic stem cell research through a comparative analysis of the diverging interpretations which have emerged in the regulations of US, EU and China. Many pieces of Jiang’s work have been published by leading international journals in Australia and the United States.

Product Specifications

Brand: Springer
Colour: White
Format: paperback
ASIN: 9811095280
Category: Books > Subjects > Business, Finance & Law > Law > International
Domain: Amazon UK
Release Date: 12 June 2018
Listed Since: 11 June 2018

Barcode

No barcode data available

Springer Regulating Human Embryonic Stem Cell in China: A Comparative Study on Human Embryonic Stem Cell’s Patentability and Morality in US and EU

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Regulatory Model for Digital Rights Management: Analysis of U.S., Europe and China

Competition Law in China: A Law and Economics Perspective

Translational Stem Cell Research: Issues Beyond the Debate on the Moral Status of the Human Embryo (Stem Cell Biology and Regenerative Medicine)

International Patent Rights Harmonisation: The Case of China

Imitation to Innovation in China: The Role of Patents in Biotechnology and Pharmaceutical Industries (New Horizons in Intellectual Property series)

Mesenchymal Stem Cells - Basics and Clinical Application II: 130 (Advances in Biochemical Engineering/Biotechnology, 130)

Mesenchymal Stem Cells - Basics and Clinical Application II: 130 (Advances in Biochemical Engineering/Biotechnology, 130)

Human Embryonic Stem Cells Handbook: 873 (Methods in Molecular Biology, 873)

The Patentability of Synthetic Biology Inventions: New Technology, Same Patentability Issues?

Bioinked Boundaries: Patenting 3D Bioprinted Tissues, Organs and Bioinks: An US, European and Australian Patent Law Perspective

Concise Chinese Tort Laws: 1 (China-EU Law Series, 1)

The Patentability of Synthetic Biology Inventions: New Technology, Same Patentability Issues?

Bioreactor Systems for Tissue Engineering II: Strategies for the Expansion and Directed Differentiation of Stem Cells: 123 (Advances in Biochemical Engineering/Biotechnology, 123)

Chinese Intellectual Property and Technology Laws

Bioproperty, Biomedicine and Deliberative Governance: Patents as Discourse on Life (Globalization and Law)

Bioreactor Systems for Tissue Engineering II: Strategies for the Expansion and Directed Differentiation of Stem Cells: 123 (Advances in Biochemical Engineering/Biotechnology, 123)

Compulsory Education Policy in China: Concept and Practice (Exploring Education Policy in a Globalized World: Concepts, Contexts, and Practices)

Maintenance Time and the Industry Development of Patents: Empirical Research with Evidence from China

National Security Review of Foreign Investment: A Comparative Legal Analysis of China, the United States and the European Union (The Rule of Law in China and Comparative Perspectives)

Economic Impacts of Intellectual Property-Conditioned Government Incentives

Die Patentfähigkeit von Arzneimitteln: Der gewerbliche Rechtsschutz für pharmazeutische, medizinische und biotechnologische Erfindungen: 14 ... Universitäten Heidelberg und Mannheim, 14)

Bioproperty, Biomedicine and Deliberative Governance: Patents as Discourse on Life (Globalization and Law)

Stem Cells & Regenerative Medicine: From Molecular Embryology to Tissue Engineering (Stem Cell Biology and Regenerative Medicine)

Chinese Lawmaking: From Non-communicative to Communicative (Understanding China)